“…In a subanalysis of the Prevention of Events With Angiotensin-Converting Enzyme Inhibition (PEACE) trial, which evaluated the prognostic value of baseline BNP and NTproBNP levels in 3761 patients with low-risk, stable coronary artery disease and preserved left ventricular function, 21 BNP was an independent predictor of an increased risk of heart failure development, while NTproBNP was independently 8,11,15,17,19,20,29 Non-ST-elevation myocardial infarction [11][12][13][14][15]17,20,27,29,32 Acute coronary syndrome in the absence of detectable myocardial necrosis (unstable angina) 9,12,13,15,27,29,32 Uncomplicated percutaneous coronary intervention in the presence of stable intracardiac filling pressure 12,16 Stable coronary artery disease 6,[21][22][23][24][25][26][28][29][30] natriuretic peptides in ACS july . august 2008 .…”